ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 150 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $46,094 | -19.9% | 90,379 | -1.0% | 0.00% | – |
| Q1 2023 | $57,541 | +95801.7% | 91,335 | 0.0% | 0.00% | – |
| Q4 2022 | $60 | -100.0% | 91,335 | 0.0% | 0.00% | – |
| Q3 2022 | $157,000 | +20.8% | 91,335 | -13.3% | 0.00% | – |
| Q2 2022 | $130,000 | +88.4% | 105,342 | 0.0% | 0.00% | – |
| Q1 2022 | $69,000 | -40.0% | 105,342 | 0.0% | 0.00% | – |
| Q4 2021 | $115,000 | -39.5% | 105,342 | +1.2% | 0.00% | – |
| Q3 2021 | $190,000 | -57.8% | 104,126 | -38.9% | 0.00% | – |
| Q2 2021 | $450,000 | -27.5% | 170,295 | -1.3% | 0.00% | – |
| Q1 2021 | $621,000 | +750.7% | 172,486 | +494.8% | 0.00% | – |
| Q4 2020 | $73,000 | -47.1% | 29,000 | +89.5% | 0.00% | – |
| Q3 2015 | $138,000 | -45.2% | 15,302 | -27.2% | 0.00% | – |
| Q2 2015 | $252,000 | – | 21,024 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |